Tisheeka Graham

790 total citations
10 papers, 652 citations indexed

About

Tisheeka Graham is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tisheeka Graham has authored 10 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tisheeka Graham's work include Cancer Cells and Metastasis (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Prostate Cancer Treatment and Research (2 papers). Tisheeka Graham is often cited by papers focused on Cancer Cells and Metastasis (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Prostate Cancer Treatment and Research (2 papers). Tisheeka Graham collaborates with scholars based in United States. Tisheeka Graham's co-authors include Valerie Odero-Marah, Ruth O’Regan, Tongrui Liu, Mourad Tighiouart, Adeboye O. Osunkoya, K. Sean Kimbro, Jonathan W. Simons, Haiyen E. Zhau, Leland W.K. Chung and Valerie Odero‐Marah and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Tisheeka Graham

10 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tisheeka Graham United States 7 429 340 206 173 48 10 652
Dianqi Xin China 13 421 1.0× 157 0.5× 108 0.5× 205 1.2× 41 0.9× 35 560
Allen Saliganan United States 12 263 0.6× 275 0.8× 202 1.0× 181 1.0× 24 0.5× 14 605
Diana G. Wang United States 6 496 1.2× 170 0.5× 165 0.8× 225 1.3× 48 1.0× 8 749
Gloria Manzotti Italy 14 612 1.4× 221 0.7× 124 0.6× 255 1.5× 44 0.9× 31 918
Lindy Goddard United Kingdom 15 486 1.1× 359 1.1× 448 2.2× 195 1.1× 117 2.4× 22 927
Valerie Odero‐Marah United States 10 334 0.8× 262 0.8× 222 1.1× 139 0.8× 18 0.4× 22 593
Alexandre Arcaro Switzerland 14 393 0.9× 195 0.6× 80 0.4× 209 1.2× 53 1.1× 20 606
Hongtuan Zhang China 17 399 0.9× 130 0.4× 118 0.6× 210 1.2× 33 0.7× 21 623
Luis A. Martinez United States 9 384 0.9× 351 1.0× 153 0.7× 106 0.6× 16 0.3× 9 584
Hideaki Dote Japan 12 627 1.5× 194 0.6× 126 0.6× 138 0.8× 24 0.5× 15 779

Countries citing papers authored by Tisheeka Graham

Since Specialization
Citations

This map shows the geographic impact of Tisheeka Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tisheeka Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tisheeka Graham more than expected).

Fields of papers citing papers by Tisheeka Graham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tisheeka Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tisheeka Graham. The network helps show where Tisheeka Graham may publish in the future.

Co-authorship network of co-authors of Tisheeka Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Tisheeka Graham. A scholar is included among the top collaborators of Tisheeka Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tisheeka Graham. Tisheeka Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Henderson, Veronica, et al.. (2012). Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells. BMC Cancer. 12(1). 336–336. 27 indexed citations
2.
Liu, Tongrui, Rami Yacoub, LaTonia Taliaferro‐Smith, et al.. (2011). Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells. Molecular Cancer Therapeutics. 10(8). 1460–1469. 88 indexed citations
3.
Graham, Tisheeka, et al.. (2010). Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells. The Prostate. 70(9). 982–992. 84 indexed citations
5.
Graham, Tisheeka, Rami Yacoub, LaTonia Taliaferro‐Smith, et al.. (2009). Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. Breast Cancer Research and Treatment. 123(1). 139–147. 67 indexed citations
7.
Yacoub, Rami, et al.. (2009). Effect of mTOR inhibition on sensitivity of triple-negative breast cancer cells to epidermal growth factor inhibition. Journal of Clinical Oncology. 27(15_suppl). 1055–1055. 4 indexed citations
8.
Graham, Tisheeka, Valerie Odero‐Marah, Adeboye O. Osunkoya, et al.. (2008). IGF-I-dependent upregulation of ZEB1 expression drives EMT in human prostate cancer cells in vitro. Cancer Research. 68. 3585–3585. 1 indexed citations
9.
Graham, Tisheeka, Valerie Odero-Marah, Leland W.K. Chung, et al.. (2008). PI3K/Akt‐dependent transcriptional regulation and activation of BMP‐2‐Smad signaling by NF‐κB in metastatic prostate cancer cells. The Prostate. 69(2). 168–180. 41 indexed citations
10.
Graham, Tisheeka, Haiyen E. Zhau, Valerie Odero-Marah, et al.. (2008). Insulin-like Growth Factor-I–Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells. Cancer Research. 68(7). 2479–2488. 310 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026